Project Number 2R44AG043278-06A1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator DEWJI, NAZNEEN N Principal Investigator First Name NAZNEEN Principal Investigator Last Name DEWJI Awardee Organization CENNA BIOSCIENCES, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-333: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed FY Overall Cost $1,750,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE Related Resources Repository [AlzPED] Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's disease
